30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Roger Jeffs

Insider profile

Currently holds a position at Axsome Therapeutics Inc

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 18% 68% 82%
Transactions
10 40% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Lead Independent Director Axsome Therapeutics Inc Jan. 1, 2016 -
Independent Director Dova Pharmaceuticals Inc May 1, 2017 - Nov. 12, 2019
Independent Director Axovant Gene Therapies Ltd Feb. 12, 2018 - Aug. 1, 2019
President, Co-Chief Executive Officer United Therapeutics Corp June 21, 2016 - June 26, 2016
President, Co-Chief Executive Officer, Director United Therapeutics Corp Jan. 1, 2015 - June 21, 2016
Independent Director Axsome Therapeutics Inc Dec. 1, 2014 - Jan. 1, 2016
President, Chief Operating Officer, Director United Therapeutics Corp Jan. 1, 2002 - Jan. 1, 2015

Roger Jeffs's trades of Axsome Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-11 2026-06-11 PlS Planned sale
77,391 +34.5%
98.26
US$3,113,341
77,391 +34.5% 98.26 US$3,113,341
2026-06-11 2026-06-11 PlS Planned sale
13,339 +21.9%
198.61
US$4,959,478
13,339 +21.9% 198.61 US$4,959,478
2026-06-11 2026-06-11 PlS Planned sale
94,426 -44.5%
273.27
US$4,779,563
94,426 -44.5% 273.27 US$4,779,563
2026-06-11 2026-06-11 PrS Proposed sale
286
249.12
US$71,248
286 249.12 US$71,248
2026-06-11 2026-06-10 PlS Planned sale
286 -0.5%
246.18
US$70,407
286 -0.5% 246.18 US$70,407
2026-06-10 2026-06-10 PrS Proposed sale
286
246.18
US$70,407
286 246.18 US$70,407
2026-05-28 2026-05-27 PlS Planned sale
6,428 -0.6%
62.18
US$399,712
6,428 -0.6% 62.18 US$399,712
2026-05-26 2026-05-26 PlS Planned sale
25,000 -2.3%
60.38
US$1,509,460
25,000 -2.3% 60.38 US$1,509,460
2026-05-26 2026-05-22 PlS Planned sale
25,000 -2.3%
61.52
US$1,538,055
25,000 -2.3% 61.52 US$1,538,055
2026-05-26 2026-05-21 PlS Planned sale
25,000 -2.2%
61.13
US$1,528,160
25,000 -2.2% 61.13 US$1,528,160
2026-05-20 2026-05-20 PlS Planned sale
25,000 -2.2%
61.30
US$1,532,548
25,000 -2.2% 61.30 US$1,532,548
2026-05-20 2026-05-20 PrS Proposed sale
106,428
59.98
US$6,383,551
106,428 59.98 US$6,383,551
2026-05-20 2026-05-19 PlS Planned sale
25,000 -2.1%
58.65
US$1,466,142
25,000 -2.1% 58.65 US$1,466,142
2026-05-20 2026-05-18 PlS Planned sale
25,000 -2.1%
56.77
US$1,419,320
25,000 -2.1% 56.77 US$1,419,320
2026-05-15 2026-05-15 PlS Planned sale
25,000 -2.0%
57.04
US$1,426,072
25,000 -2.0% 57.04 US$1,426,072
2026-05-15 2026-05-14 PlS Planned sale
25,000 -2.0%
58.62
US$1,465,565
25,000 -2.0% 58.62 US$1,465,565
2026-05-14 2026-05-14 PrS Proposed sale
100,000
57.59
US$5,759,000
100,000 57.59 US$5,759,000
2026-05-15 2026-05-13 PlS Planned sale
25,000 -2.0%
56.29
US$1,407,128
25,000 -2.0% 56.29 US$1,407,128
2026-05-12 2026-05-12 PlS Planned sale
25,000 -1.9%
54.04
US$1,350,990
25,000 -1.9% 54.04 US$1,350,990
2026-05-12 2026-05-11 PlS Planned sale
25,000 -1.9%
41.50
US$1,037,402
25,000 -1.9% 41.50 US$1,037,402
2026-05-12 2026-05-08 PlS Planned sale
25,000 -1.9%
42.14
US$1,053,565
25,000 -1.9% 42.14 US$1,053,565
2026-05-08 2026-05-08 PrS Proposed sale
100,000
42.28
US$4,228,000
100,000 42.28 US$4,228,000
2026-05-07 2026-05-07 PlS Planned sale
25,000 -1.8%
42.09
US$1,052,135
25,000 -1.8% 42.09 US$1,052,135
2026-05-07 2026-05-07 PrS Proposed sale
25,000
42.14
US$1,053,500
25,000 42.14 US$1,053,500
2026-05-07 2026-05-06 PlS Planned sale
25,000 -1.8%
40.78
US$1,019,572
25,000 -1.8% 40.78 US$1,019,572
2026-05-07 2026-05-05 PlS Planned sale
25,000 -1.8%
40.10
US$1,002,593
25,000 -1.8% 40.10 US$1,002,593
2026-04-21 2026-04-17 PlS Planned sale
18,839 -1.3%
40.60
US$764,956
18,839 -1.3% 40.60 US$764,956
2026-04-17 2026-04-17 PrS Proposed sale
68,839
41.40
US$2,849,935
68,839 41.40 US$2,849,935
2026-04-16 2026-04-16 PlS Planned sale
25,000 -1.7%
40.31
US$1,007,800
25,000 -1.7% 40.31 US$1,007,800
2026-04-16 2026-04-16 PrS Proposed sale
25,000
40.12
US$1,003,000
25,000 40.12 US$1,003,000
2026-04-16 2026-04-15 PlS Planned sale
25,000 -1.7%
40.14
US$1,003,522
25,000 -1.7% 40.14 US$1,003,522
2026-04-15 2026-04-15 PrS Proposed sale
24,733
38.71
US$957,414
24,733 38.71 US$957,414
2026-04-16 2026-04-14 PlS Planned sale
3,300 -0.2%
40.00
US$132,000
3,300 -0.2% 40.00 US$132,000
2026-04-14 2026-04-13 PlS Planned sale
32,744 -2.8%
38.37
US$1,256,387
32,744 -2.8% 38.37 US$1,256,387
2026-04-14 2026-04-10 PlS Planned sale
21,433 -1.4%
40.12
US$859,877
21,433 -1.4% 40.12 US$859,877
2026-04-10 2026-04-10 PrS Proposed sale
25,000
40.32
US$1,008,000
25,000 40.32 US$1,008,000
2026-04-13 2026-04-09 PlS Planned sale
25,000 -1.6%
40.12
US$1,002,887
25,000 -1.6% 40.12 US$1,002,887
2026-04-09 2026-04-09 PrS Proposed sale
25,000
38.19
US$954,750
25,000 38.19 US$954,750
2026-01-13 2026-01-12 PlS Planned sale
66,610 -6.0%
37.43
US$2,493,212
66,610 -6.0% 37.43 US$2,493,212
2025-10-15 2025-10-13 PlS Planned sale
20,261 -1.9%
23.41
US$474,310
20,261 -1.9% 23.41 US$474,310
2025-09-02 2025-09-02 PrS Proposed sale
13,464
123.68
US$1,665,162
13,464 123.68 US$1,665,162
2025-09-02 2025-09-02 PlS Planned sale
13,464 -19.0%
123.68
US$1,665,228
13,464 -19.0% 123.68 US$1,665,228
2025-08-29 2025-08-29 PrS Proposed sale
20,000
121.27
US$2,425,335
20,000 121.27 US$2,425,335
2025-08-29 2025-08-29 PlS Planned sale
20,000 -22.0%
121.27
US$2,425,400
20,000 -22.0% 121.27 US$2,425,400
2025-08-29 2025-08-28 PlS Planned sale
20,000 -18.0%
121.60
US$2,432,000
20,000 -18.0% 121.60 US$2,432,000